Literature Ard Peeters (15 January 2019)

  1. Peeters B. Zijn mensen met overgewicht sterk gemotiveerd om ongezond te eten? NTVD 4 30-31, 2018.
  2. van Aken M, Oosterman J, van Rijn T, Woudsma K, Ferdek M, Ruigt G, Kozicz T, Braat D, Peeters A, Nap A. Experimental pain tolerance is decreased and independent of clinical pain intensity in patients with endometriosis. Fertil Steril.110(6):1118-1128, 2018.
  3. van Aken MAW. Oosterman JM. van Rijn CM. Ferdek MA. Ruigt GSP. Kozicz TL. Braat DDM. Peeters BWMM. Nap AW. Hair cortisol analysis in patients with endometriosis: something to stress about? Psychoneuroendocrinology 89: 216-222, 2018.
  4. Aalbers T. Zonneveld A. Leij-Halfwerk S. van Oers S. Peeters B. Eetverslaving als oorzaak voor obesitas. Proof of principle voor een nieuwe methode om de cliënt-specifieke verslaving te karakteriseren. Voeding en Visie, zomer 2017.
  5. van Aken MAW. Oosterman JM. van Rijn CM. Ferdek MA. Ruigt GSP. Peeters BWMM. Braat DDM. Nap AW. Pain cognition versus pain intensity in patients with endometriosis: toward personalized treatment. Fertil. Steril. 108(4) 679-686, 2017.
  6. Peeters BWMM. VandenBreemer J. Computer-implemented method and mobile device for monitoring person behaviour. NL2017414.
  7. Verdouw MP. Esterik van JCJ. Peeters BWMM. Millan MJ. Groenink L. CRF1but not glucocorticoid receptor antagonists reduce separation-induced distress vocalizations in guinea pig pups and CRF overexpressing mouse pups. A combination study with paroxetine. Pharmacol. Biochem. Behav. 154 11-19, 2017.
  8. Peeters BW. Moeskops, M. Veenvliet AR. Color preference in Danio rerio: effects of age and anxiolytic treatments. Zebrafish 13(4) 330-334, 2016.
  9. Peeters BWMM. Zonneveld AJ. Use of selected N-phenyl benzamide variants for the stimulation of osteoblast activity and for the treatment of Osteoporosis and related disorders.
  10. Flik G. Metz J. de Vrieze E. Peeters BWMM. A method to measure therapeutic effects of a compound on bone formation or degradation. EP12075131.8.
  11. Peeters BWMM. Broekkamp CLE. Means to facilitate food intake and food retention by administration of local anesthetics.
  12. Sterrenburg L. Borch A.  Peeters BWMM. Pinter O. Zelena D. Roubos EW. Kozicz T. Acute ether stress differentially affects corticotropin-releasing factor and urocortin in the Brattleboro rat. [Journal Article] Brain Res 1398 21-29, 2011.
  13. Sterrenburg L. Gaszner B. Boerrigter J. Santbergen L. Bramini M. Elliot E. Chen A. Roubos EW. Peeters BWMM. Kozicz T. Chronic stress induces sex-specific alterations in methylation and expression of corticotropin-releasing factor gene in the rat. [Journal Article] PLoS ONE 6(11), 2011.
  14. Sterrenburg L. Gaszner B. Boerrigter J. Santbergen L. Bramini M. Roubos EW. Peeters BWMM. Kozicz T. Sex dependent and differential responses to acute restraint stress of corticotropin-releasing factor-producing neurons in the rat paraventricular nucleus, central amygdala and bed nucleus of the stria terminalis. [Journal Article] J. Neurosci Res. 90(1) 179-192, 2012.
  15. Jacobs GE. Hulskotte EGJ. de Kam ML. Elassaiss-Schaap J. Ruigt G, van Pelt J. Peeters BWMM. Peeters PAM. van Gerven JMA. A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal (HPA) axis more integrally in healthy volunteers. [Journal Article] J Psychopharm 25(3) 361-369, 2011.
  16. Russell G. Henley D. Leendertz J. Douthwaite J. Wood S. Stevens A. Woltersdorf W. Peeters B. Ruigt G. White A. Veldhuis J. Lightman S. Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males. [Journal Article] J Neurosci 30(10):6106-6115, 2010.
  17. Jacobs GE. Hulskotte EGJ. van Gerven JMA. Zuurman L. de Kam ML. Elassaiss-Schaap J. Ruigt G, van Pelt J. Peeters BWMM. Peeters PAM. Burggraaf  J. Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary-adrenal (HPA) axis modulation: neuroendocrine, cardiovascular and coagulatory effects. [Journal Article] J Psychopharm 25(3) 353-360,2011.
  18. Spiga F. Knight DM. Droste SK. Conway-Campbell B. Kershaw Y. MacSweeney CP. Thomson FT. Craighead M. Peeters BWMM. Lightman SL. Differential effect of glucocorticoid receptor antagonists on glucocorticoid receptor nuclear translocation and DNA binding. [Journal Article] J Psychopharm 25(2)211-221, 2011.
  19. Peeters BWMM. Adang AEP. S-Mirtazapine for the treatment of hot flush. [Patent application] US2007667579A, 2007.
  20. Peeters BWMM. Sennef C. Treatment of major depressive disorder using glucocorticoid receptor antagonists. [Patent application] WO2002EP12854A, 2002.
  21. Wuest F. Henry B. Peeters B. Wiegerinck P. Kniess T. Pietzsch J. Bergmann R. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer. [Journal Article] Applied Radiation & Isotopes 67(2):308-312, 2009.
  22. Fitzsimons CP. van Hooijdonk LWA Morrow J. Peeters B. Hamilton N. Craighead M. Vreugdenhil E. Antiglucocorticoids, neurogenesis and depression. [Journal Article] Mini-Reviews in Medicinal Chemistry 9:249-264, 2009.
  23. Peeters BWMM. GR antagonists, that can pass the blood-brain barrier, can prevent or diminish cognitive disturbances that are induced or aggravated by SSRIs. [Patent application] 2007.
  24. Peeters BWMM. Use of glucocorticoid receptor antagonists for treatment of infectious conditions. [Patent application] EPPD2006.946.
  25. Groenink L. Dirks A. Verdouw PM. De Graaff M. Peeters BW. Millan MJ. Olivier B. CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice over-expressing CRF. [Journal Article] Biol Psychiatry 63(4): 360-8, 2007.
  26. Peeters BWMM. Ruigt GSF. Craighead M. Kitchener P. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line. [Journal Article] Annals of the New York Academy of Sciences 114:536-541, 2008.
  27. Peeters BWMM. Tonnaer JADM. Groen MB. Broekkamp CLE. Van der Voort HAA. Schoonen WGFJ. Smets RJM. VanderHeyden PML. Gebhard R. Ruigt GSF. Glucocorticoid receptor antagonists: New tools to investigate disorders characterised by cortisol hypersecretion. [Journal Article] Stress 7(4):233-41,2004.
  28. Peeters BWMM. Sennef C. Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists. [Patent application] EP01204518.3, 2001.
  29. Peeters BWMM. Sennef C. Use of (11ß,17ß)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one in the treatment of major depressive disorder. [Patent application] EP01204072.1, 2001.
  30. Joordens RJ. Hijzen TH. Peeters BW. Olivier B. Control conditions in the fear-potentiated startle response paradigm. [Journal Article] Neuroreport. 8(4):1031-4, 1997.
  31. Joordens RJ. Hijzen TH. Peeters BW. Olivier B. Fear-potentiated startle response is remarkably similar in two laboratories. [Journal Article] Psychopharmacology. 126(2):104-9, 1996.
  32. Berendsen HH. Kester RC. Peeters BW. Broekkamp CL. Modulation of 5-HT receptor subtype-mediated behaviours by corticosterone. [Journal Article] European Journal of Pharmacology. 308(2):103-11, 1996.
  33. Broekkamp CL. Leysen D. Peeters BW. Pinder RM. Prospects for improved antidepressants. [Review] [196 refs] [Journal Article. Review. Review, Academic] Journal of Medicinal Chemistry. 38(23):4615-33, 1995.
  34. Reijmers LG. Vanderheyden PM. Peeters BW. Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens. [Journal Article] European Journal of Pharmacology. 272(2-3):131-8, 1995.
  35. Peeters BWMM. Antiglucocorticoid steroids for the treatment of anxiety disorders. [Patent application] WO95/04536, 1994.
  36. Reijmers LG. Peeters BW. Effects of acoustic prepulses on the startle reflex in rats: a parametric analysis.[republished from Brain Res. 1994 Oct 24;661(1-2):174-80; PMID: 7834367]. [Corrected and Republished Article. Journal Article] Brain Research. 667(1):144-50, 1994.
  37. Reijmers LG. Peeters BW. Acoustic prepulses can facilitate the startle reflex in rats: discrepancy between rat and human data resolved. [Journal Article] Brain Research Bulletin. 35(4):337-8, 1994.
  38. Reijmers LG. Peeters BW. Effects of acoustic prepulses on the startle reflex in rats: a parametric analysis.[republished in Brain Res. 1994 Dec 19;667(1):144-50; PMID: 7895078]. [Journal Article] Brain Research. 661(1-2):174-80, 1994.
  39. Peeters BW. van der Heijden R. Gubbels DG. Vanderheyden PM. Effects of chronic antidepressant treatment on the hypothalamic-pituitary-adrenal axis of Wistar rats. [Journal Article] Annals of the New York Academy of Sciences. 746:449-52, 1994.
  40. Peeters BW. Broekkamp CL. Involvement of corticosteroids in the processing of stressful life-events. A possible implication for the development of depression. [Journal Article] Journal of Steroid Biochemistry & Molecular Biology. 49(4-6):417-27, 1994.
  41. Peeters BW. Ramakers GM. Ellenbroek BA. Vossen JM. Coenen AM. Interactions between NMDA and nonNMDA receptors in nonconvulsive epilepsy in the WAG/Rij inbred strain. [Journal Article] Brain Research Bulletin. 33(6):715-8, 1994.
  42. Peeters BW. Ramakers GM. Vossen JM. Coenen AM. The WAG/Rij rat model for nonconvulsive absence epilepsy: involvement of nonNMDA receptors. [Journal Article] Brain Research Bulletin. 33(6):709-13, 1994.
  43. De Beun R. Peeters BW. Broekkamp CL. Stimulus characterization of estradiol applying a crossfamiliarization taste aversion procedure in female mice. [Journal Article] Physiology & Behavior. 53(4):715-9, 1993.
  44. Peeters BW. Vanderheyden PM. In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site. [Journal Article] Epilepsy Research. 12(2):157-62, 1992.
  45. Peeters BW. Cheung KS. Vossen JM. Coenen AM. Some solvents for antiepileptics have proepileptic potencies in the WAG/Rij rat model for absence epilepsy. [Journal Article] Brain Research Bulletin. 29(3-4):515-7, 1992.
  46. Peeters BW. Kerbusch JM. Coenen AM. Vossen JM. van Luijtelaar EL. Genetics of spike-wave discharges in the electroencephalogram (EEG) of the WAG/Rij inbred rat strain: a classical mendelian crossbreeding study. [Journal Article] Behavior Genetics. 22(3):361-8, 1992.
  47. Peeters BW. Smets RJ. Broekkamp CL. Sex steroids possess distinct stimulus properties in female and male mice. [Journal Article] Brain Research Bulletin. 28(2):319-21, 1992.
  48. Cools AR. Peeters BW. Differences in spike-wave discharges in two rat selection lines characterized by opposite dopaminergic activities. [Journal Article] Neuroscience Letters. 134(2):253-6, 1992.
  49. Tonnaer JA. Schuijers GJ. Van Diepen HA. Peeters BW. Enhancement of regeneration by Org 2766 after nerve crush depends on the type of neural injury. [Journal Article] European Journal of Pharmacology. 214(1):33-7, 1992.
  50. Peeters BW. Smets RJ. Broekkamp CL. The involvement of glucocorticoids in the acquired immobility response is dependent on the water temperature. [Journal Article] Physiology & Behavior. 51(1):127-9, 1992.
  51. Ramakers GM. Peeters BW. Vossen JM. Coenen AM. CNQX, a new non-NMDA receptor antagonist, reduces spike wave discharges in the WAG/Rij rat model of absence epilepsy. [Journal Article] Epilepsy Research. 9(2):127-31, 199l.
  52. Coenen AM. Drinkenburg WH. Peeters BW. Vossen JM. van Luijtelaar EL. Absence epilepsy and the level of vigilance in rats of the WAG/Rij strain. [Journal Article] Neuroscience & Biobehavioral Reviews. 15(2):259-63, 1991.
  53. Inoue M. Peeters BW. van Luijtelaar EL. Vossen JM. Coenen AM. Spontaneous occurrence of spike-wave discharges in five inbred strains of rats. [Journal Article] Physiology & Behavior. 48(1):199-201, 1990.
  54. Peeters BW. van Rijn CM. Vossen JM. Coenen AM. Involvement of NMDA receptors in non-convulsive epilepsy in WAG/Rij rats. [Journal Article] Life Sciences. 47(6):523-9, 1990.
  55. Peeters BW. Kerbusch JM. van Luijtelaar EL. Vossen JM. Coenen AM. Genetics of absence epilepsy in rats. [Journal Article] Behavior Genetics. 20(3):453-60, 1990.
  56. Peeters BW. Van Rijn CM. Nutt DJ. Titulaer MN. Vossen JM. Coenen AM. Diazepam and Ro 15-1788 increase absence epilepsy in WAG/Rij rats chronically exposed to diazepam. [Journal Article] European Journal of Pharmacology. 178(1):111-4, 1990.
  57. Peeters BW. Van Luijtelaar EL. Coenen AM. Absence epilepsy in rats is reduced by deprivation of REM sleep. [Journal Article] Physiology & Behavior. 46(2):115-9, 1989.
  58. Peeters BW. van Rijn CM. Vossen JM. Coenen AM. Effects of GABA-ergic agents on spontaneous non-convulsive epilepsy, EEG and behaviour, in the WAG/RIJ inbred strain of rats. [Journal Article] Life Sciences. 45(13):1171-6, 1989.
  59. Peeters BW. Van Rijn CM. Van Luijtelaar EL. Coenen AM. Antiepileptic and behavioural actions of MK-801 in an animal model of spontaneous absence epilepsy.[erratum appears in Epilepsy Res 1989 Nov-Dec;4(3):234]. [Journal Article] Epilepsy Research. 3(2):178-81, 1989.
  60. Peeters BWMM. Spooren WPJM. vanLuijtelaar ELJM. Coenen AML. The WAG/Rij rat model for absence epilepsy: Anticonvulsant drug evaluation. Neuroscience Research Communications 2(2):93-7, 1988.
  61. Ellenbroek BA. Peeters BW. Honig WM. Cools AR. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs. [Journal Article] Psychopharmacology. 93(3):343-8, 1987.
  62. Cools AR. Peeters BWMM. Behavioral function of neostriatal glutamate and its interaction with Dopamine. [Journal Article] Neuroscience Research Communication 1(1):47-55, 1987.